Es posible tomar demasiada vitamina D, como averiguó un hombre de la peor manera
MIÉRCOLES, 6 de julio de 2022 (HealthDay News) — Con frecuencia, se promocionan los complementos de vitamina D por sus beneficios de salud, desde potenciar el sistema inmunitario hasta proteger del cáncer. Pero, como averiguó un hombre británico, sí …
Learn MoreGrief Can Be Heartbreaking for People Battling Heart Failure
WEDNESDAY, July 6, 2022 (HealthDay News) — Can someone really die of a broken heart?If that person has serious heart disease, new Swedish research suggests the answer may well be yes.After analyzing almost three decades worth of data on nearly half a…
Learn MoreCancer Drug May Be Lifesaver for Hospitalized COVID Patients
WEDNESDAY, July 6, 2022 (HealthDay News) — An experimental drug used to fight cancer may reduce the risk of death for COVID-19 patients by roughly 55%, a new study suggests.The drug, sabizabulin, has been found effective in aiding severely ill COVID-…
Learn MoreVaccinations Cut U.S. COVID Deaths by 58%: Study
WEDNESDAY, July 6, 2022 (HealthDay News) — The U.S. COVID-19 vaccination program slashed the coronavirus’ expected death rate by as much as 58%, saving hundreds of thousands of lives during the first two waves of the pandemic, a new study says.Comput…
Learn MoreImpact of Affiliation Mixed for Rural U.S. Hospitals
WEDNESDAY, July 6, 2022 (HealthDay News) — Affiliation may protect some financially distressed rural hospitals from closure, according to a study published online July 1 in JAMA Health Forum.H. Joanna Jiang, Ph.D., from the Agency for Healthcare Rese…
Learn MorePTSD Linked to Faster Cognitive Decline in Middle-Aged Women
WEDNESDAY, July 6, 2022 (HealthDay News) — Posttraumatic stress disorder (PTSD) is associated with accelerated cognitive decline among middle-aged women, according to a study published online June 30 in JAMA Network Open.Andrea L. Roberts, Ph.D., M.P…
Learn MoreSevere COVID-19 Rates Low With Monoclonal Antibody Therapy During Delta Surge
WEDNESDAY, July 6, 2022 (HealthDay News) — Real-world data show that the rates of severe disease were low among high-risk patients with mild-to-moderate COVID-19 who received treatment with antispike monoclonal antibody products during the delta surg…
Learn MoreExperts Address Managing Cancer-Related Pain in Setting of Opioid Abuse, Misuse
WEDNESDAY, July 6, 2022 (HealthDay News) — In a qualitative study published online June 30 in JAMA Oncology, consensus-based guidance is provided for managing advanced cancer-related pain in patients with opioid use disorder (OUD) or opioid misuse.Ka…
Learn MoreGaps ID’d in Hospitals’ Likelihood of Adopting Stroke Care Certification
WEDNESDAY, July 6, 2022 (HealthDay News) — Hospitals in low-income and rural communities have a lower likelihood of receiving stroke care certification, according to a study published online June 27 in JAMA Neurology.Yu-Chu Shen, Ph.D., from the Nava…
Learn MoreWhite Matter Hyperintensity Burden Up for Postmenopausal Women
WEDNESDAY, July 6, 2022 (HealthDay News) — Postmenopausal women appear to have a higher burden of white matter hyperintensity (WMH) than similar-aged men and women who are premenopausal, according to a study published online June 29 in Neurology.Vale…
Learn More